Literature DB >> 31739367

Low Fetal Fraction and Birth Weight in Women with Negative First-Trimester Cell-Free DNA Screening.

Mark A Clapp1, Margaret Berry1, Lydia L Shook1, Penelope S Roberts1, Ilona T Goldfarb1, Sarah N Bernstein1.   

Abstract

OBJECTIVE: To determine the association between low fetal fraction and birth weight among women with a negative cell-free DNA (cfDNA) result for common aneuploidies in the first trimester. STUDY
DESIGN: This is a retrospective cohort of women who delivered a singleton between July 2016 and June 2018 at a single institution and had normal cfDNA testing in the first trimester. The primary variable of interest was "low fetal fraction," which was defined as fetal fractions less than 5th percentile among all fetal fractions in the cohort (fetal fraction < 5.34%). The primary outcomes were birth weight ≤ 5th and ≤ 10th percentiles. Multivariable logistic regressions assessed for the association between low fetal fraction and birth weight.
RESULTS: A total of 7,478 women delivered a singleton at ≥24 weeks' gestation, of which 2,387 (32%) underwent genetic screening through cfDNA; the majority were in the first trimester (n = 2,052 [86%]). 2,035 met the inclusion criteria. Birth weight ≤ 5th percentile was significantly higher in the low fetal fraction group (6.9 vs. 3.2%; p = 0.04). A low fetal fraction was associated with higher odds of an infant with a low birth weight: adjusted odds ratio (aOR) of 2.32 (95% CI 1.15-4.67) for birth weight ≤ 10th percentile (p = 0.02) and aOR of 3.73 (95% CI 1.40-9.03) for birth weight ≤ 5th percentile (p = 0.004).
CONCLUSION: Low fetal fractions of ≤ 5th percentile were associated with an increased risk of birth weights ≤ 5th and ≤ 10th percentiles in women with negative cfDNA screening in the first trimester. Future work is needed to further investigate this relationship and to determine the potential clinical implications, such as third-trimester screening for growth restriction in women with low fetal fractions and negative cfDNA screening results. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Year:  2019        PMID: 31739367     DOI: 10.1055/s-0039-1700860

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  6 in total

1.  Low Fetal Fraction of Cell Free DNA at Non-Invasive Prenatal Screening Increases the Subsequent Risk of Preterm Birth in Uncomplicated Singleton Pregnancy.

Authors:  Xiaosong Yuan; Xiaoya Han; Chenbo Jia; Wenbo Zhou; Bin Yu
Journal:  Int J Womens Health       Date:  2022-07-13

2.  The low fetal fraction at the first trimester is associated with adverse pregnancy outcomes in IVF singleton pregnancies with single embryo transfer from frozen cycles.

Authors:  Yang Zou; Hongqiang Xie; Jingmei Hu; Linlin Cui; Guangbao Liu; Lijuan Wang; Mengyang Xue; Junhao Yan; Xuan Gao; Yuan Gao; Zi-Jiang Chen
Journal:  J Assist Reprod Genet       Date:  2022-05-13       Impact factor: 3.357

3.  Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: Analysis of a subcohort of the TRIDENT-2 study.

Authors:  Ellis C Becking; Soetinah A M Wirjosoekarto; Peter G Scheffer; Julia V M Huiskes; Marinka J Remmelink; Erik A Sistermans; Caroline J Bax; Janneke M Weiss; Lidewij Henneman; Mireille N Bekker
Journal:  Prenat Diagn       Date:  2021-09-09       Impact factor: 3.242

Review 4.  Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review.

Authors:  Cechuan Deng; Shanling Liu
Journal:  Front Pediatr       Date:  2022-01-27       Impact factor: 3.418

5.  Low fetal fraction in obese women at first trimester cell-free DNA based prenatal screening is not accompanied by differences in total cell-free DNA.

Authors:  Raj Shree; Teodora R Kolarova; Hayley J MacKinnon; Jaclynne M Hedge; Elena Vinopal; Kimberly K Ma; Christina M Lockwood; Suchitra Chandrasekaran
Journal:  Prenat Diagn       Date:  2021-08-14       Impact factor: 3.242

6.  Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: A systematic review.

Authors:  Peter G Scheffer; Soetinah A M Wirjosoekarto; Ellis C Becking; Marjan M Weiss; Caroline J Bax; Dick Oepkes; Erik A Sistermans; Lidewij Henneman; Mireille N Bekker
Journal:  Prenat Diagn       Date:  2021-08-18       Impact factor: 3.242

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.